Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07475585

Effects of Auricular Point Pressing With Pellets in Children With Insufficient Hyperopia Reserve

A Randomized Controlled Trial of Auricular Point Pressing With Pellets for Children With Insufficient Hyperopia Reserve

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
380 (estimated)
Sponsor
Fangbiao Tao · Academic / Other
Sex
All
Age
4 Years – 14 Years
Healthy volunteers
Accepted

Summary

This project aims to address the trend of early onset and high myopia among children in China by focusing on insufficient hyperopia reserve, a key early warning indicator for myopia. A randomized controlled trial (RCT) will be conducted. The study will target children aged 4 to 14 with insufficient hyperopia reserve (equivalent spherical lens -0.50D to +0.75D). Through a prospective RCT design, the efficacy and safety of auricular point pressure therapy, low-concentration atropine eye drops, and their combination in delaying the onset of myopia will be systematically evaluated.

Detailed description

A total of 380 subjects are planned to be included and randomly divided into auricular point pressure pill group, atropine group, combined group and control group. The follow-up period is 18 months (12 months of intervention + 6 months after intervention). The primary endpoints are changes in spherical equivalent and axial length of the eye. The secondary endpoints include intraocular pressure, astigmatism and adverse events.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEar acupoint pressure pellet intervention groupAccording to the subject's choice or the doctor's advice, auricular point pressing with pellets is selected, and the application is changed once a week. During the operation, first press and hold the auricular points of "Ear Gate", "Auditory Palace", and "Auditory Meeting" for 30 seconds each; then rub the ears until they feel slightly warm and slightly red; then apply auricular point pressing with pellets to the points of "Spirit Gate", "Eye 1", "Eye 2", "Eye", "Kidney", "Liver", and "Spleen". This method can stimulate the meridians, regulate the qi of the eye meridians, improve the blood circulation of the children's eyes, and thereby relieve the spasm of the ciliary muscle.
DRUGAtropine intervention groupInitial treatment: 1 time per night, apply 0.01% atropine eye drops to both eyes (brand name: Xingqi Meioupin, Xingqi Pharmaceutical, 30 drops per box). If the refractive error of myopia progresses by ≥0.25D every 6 months or the eye axis grows by ≥0.1mm every 6 months, then increase to 0.01% atropine eye drops 2 times per day.
COMBINATION_PRODUCTJoint intervention GroupReceived both auricular acupressure pill intervention and atropine intervention simultaneously
OTHERcontrol groupOnly receive standardized eye hygiene education (such as increasing outdoor activity time and controlling close distance) (such as the duration and posture of eye use, ensuring adequate sleep, etc.) Do not perform auricular point pressing pills or drug intervention

Timeline

Start date
2026-03-30
Primary completion
2027-07-30
Completion
2027-07-30
First posted
2026-03-16
Last updated
2026-03-16

Source: ClinicalTrials.gov record NCT07475585. Inclusion in this directory is not an endorsement.